1. 760 Prevalence of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: insights from the start-antiplatelet registry. (8th December 2021) Authors: Cesaro, Arturo; Gragnano, Felice; Calabrò, Paolo; Moscarella, Elisabetta; Santelli, Francesco; Fimiani, Fabio; Patti, Giuseppe; Cavallari, Ilaria; Antonucci, Emilia; Cirillo, Plinio; Pignatelli, Pasquale; Palareti, Gualtiero; Pelliccia, Francesco; Bossone, Eduardo; Pengo, Vittorio; Gresele, Paolo... Journal: European heart journal supplements Issue: Volume 23(2021)Supplement G Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 785 Sodium–glucose cotransporter 2 inhibitors in real-life patients at high cardiovascular risk. (8th December 2021) Authors: Cesaro, Arturo; Fimiani, Fabio; Gragnano, Felice; Moscarella, Elisabetta; Signore, Giovanni; Maratea, Anna Chiara; Rotolo, Francesco Paolo; Vergara, Andrea; Schiavo, Alessandra; Calabrò, Paolo Journal: European heart journal supplements Issue: Volume 23(2021)Supplement G Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience. Issue 2 (February 2018) Authors: Gragnano, Felice; Natale, Francesco; Concilio, Claudia; Fimiani, Fabio; Cesaro, Arturo; Sperlongano, Simona; Crisci, Mario; Limongelli, Giuseppe; Calabrò, Raffaele; Russo, Mariagiovanna; Golia, Enrica; Calabrò, Paolo Journal: Journal of cardiovascular medicine Issue: Volume 19:Issue 2(2018:Feb.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long‐term inhibition. (30th January 2020) Authors: Cesaro, Arturo; Bianconi, Vanessa; Gragnano, Felice; Moscarella, Elisabetta; Fimiani, Fabio; Monda, Emanuele; Scudiero, Olga; Limongelli, Giuseppe; Pirro, Matteo; Calabrò, Paolo Journal: BioFactors Issue: Volume 46:Number 3(2020) Page Start: 367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Can apical ballooning cardiomyopathy and anterior STEMI be differentiated based on β1 and β2-adrenergic receptors polymorphisms?. (15th November 2015) Authors: Vriz, Olga; Minisini, Rosalba; Zito, Concetta; Boccato, Elisa; Fimiani, Fabio; Pirisi, Mario; Facciolo, Caterina; Limongelli, Giuseppe; Bossone, Eduardo; Calabrò, Paolo Journal: International journal of cardiology Issue: Volume 199(2015) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry. (13th May 2021) Authors: Limongelli, Giuseppe; Iucolano, Stefano; Monda, Emanuele; Elefante, Pasquale; De Stasio, Chiara; Lubrano, Imma; Caiazza, Martina; Mazzella, Marialuisa; Fimiani, Fabio; Galdo, Maria; De Marchi, Giulia; Esposito, Martina; Rubino, Marta; Cirillo, Annapaola; Fusco, Adelaide; Esposito, Augusto; Trama,... Journal: Journal of public health Issue: Volume 44:Number 3(2022) Page Start: 586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. From Femoral to Radial Approach in Coronary Intervention: Review of the Literature and 6 Years Single-Center Experience. (April 2017) Authors: Bianchi, Renatomaria; D'Acierno, Ludovica; Crisci, Mario; Tartaglione, Donato; Cappelli Bigazzi, Maurizio; Canonico, Mario; Albanese, Michele; Gragnano, Felice; Fimiani, Fabio; Russo, Mariagiovanna; Cirillo, Plinio; Calabrò, Paolo Journal: Angiology Issue: Volume 68:Number 4(2017) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk. (29th August 2020) Authors: Cesaro, Arturo; Gragnano, Felice; Fimiani, Fabio; Moscarella, Elisabetta; Diana, Vincenzo; Pariggiano, Ivana; Concilio, Claudia; Natale, Francesco; Limongelli, Giuseppe; Bossone, Eduardo; Calabrò, Paolo Journal: European journal of preventive cardiology Issue: Volume 27:Number 5(2020) Page Start: 556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk. (March 2020) Authors: Cesaro, Arturo; Gragnano, Felice; Fimiani, Fabio; Moscarella, Elisabetta; Diana, Vincenzo; Pariggiano, Ivana; Concilio, Claudia; Natale, Francesco; Limongelli, Giuseppe; Bossone, Eduardo; Calabrò, Paolo Journal: European journal of preventive cardiology Issue: Volume 27:Number 5(2020) Page Start: 556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies. Issue 3 (27th March 2021) Authors: Cesaro, Arturo; Schiavo, Alessandra; Moscarella, Elisabetta; Coletta, Silvio; Conte, Matteo; Gragnano, Felice; Fimiani, Fabio; Monda, Emanuele; Caiazza, Martina; Limongelli, Giuseppe; D'Erasmo, Laura; Riccio, Carmine; Arca, Marcello; Calabrò, Paolo Journal: Journal of cardiovascular medicine Issue: Volume 22:Issue 3(2021) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗